Callan Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $872K | Buy |
11,865
+1,801
| +18% | +$132K | 0.06% | 131 |
|
|
2024
Q4 | $659K | Sell |
10,064
-863
| -8% | -$56.5K | 0.05% | 145 |
|
|
2024
Q3 | $851K | Buy |
10,927
+569
| +5% | +$44.3K | 0.06% | 125 |
|
|
2024
Q2 | $808K | Buy |
10,358
+5,277
| +104% | +$412K | 0.07% | 124 |
|
|
2024
Q1 | $344K | Sell |
5,081
-1,750
| -26% | -$119K | 0.03% | 184 |
|
|
2023
Q4 | $460K | Buy |
6,831
+1,590
| +30% | +$107K | 0.04% | 131 |
|
|
2023
Q3 | $355K | Buy |
5,241
+2,261
| +76% | +$153K | 0.04% | 143 |
|
|
2023
Q2 | $213K | Sell |
2,980
-67
| -2% | -$4.8K | 0.02% | 172 |
|
|
2023
Q1 | $211K | Hold |
3,047
| – | – | 0.02% | 169 |
|
|
2022
Q4 | $207K | Buy |
+3,047
| New | +$207K | 0.03% | 175 |
|